External Funding and collaboration

German Center for Infection Research (DZIF)

We are funded through the German Center for Infection Research (DZIF) for the development of a SARS Corona vaccine and as part of the Working Group "Clinical management and epidemiology of emerging infections".

Contact Christina Dahlke, Scientist

 

German Research Foundation

German Research Foundation / DFG

We are part of the DFG-funded Research Unit for studying sex differences in immunity.

Increasing evidence suggests that common biological pathways regulating immune cell function are involved in sex-specific differences in immunity to self (autoimmune diseases and malignancies) or to foreign (pathogens, vaccines).

Find out more on sex differences in immunity:
Research Unit 5068 | Sex differences in immunity

 

Federal Ministry of Education and Research

The BMBF funds a single center study of the immunogenicity of recombinant Vesicular Stomatitis vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP) for pre-exposure prophylaxis in individuals at potential occupational risk for Ebola virus exposure – EU Site Germany (PREPARE-Germany)

BMBF

 

CEPI

CEPI finances the two-center, randomized, double-blind, placebo-controlled, phase Ib study to assess the safety, tolerability and immunogenicity of two ascending doses of the candidate vaccine MVA-MERS-S_DF-1 in healthy study subjects

CEPI

 

netzwerk universitäts medizin

Research network of university medical centers NUM

 

Nationales Pandemie Kohorten Netz

NAPKON

 

Department for Clinical Immunology of Infectious Diseases

An expierienced researcher looking friendly at the camera
Head of Department

Prof. Dr. Marylyn M. Addo

Telefon: +49 40 285380-42

E-Mail: addo@bnitm.de

  • Logo DZIF